Iv-Kon Pharmaceuticals Private Limited
Manufactures and trades pharmaceuticals, chemicals, diagnostic reagents, and cosmetics.
1979 | Mumbai, Maharashtra (India) | Active
Iv-Kon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Company Age 45 Year, 10 Months
- Open Charges ₹ 6.06 Cr
About Iv-Kon Pharmaceuticals
Iv-Kon Pharmaceuticals Private Limited (IPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 April 1979 and has a history of 45 years and ten months. Its registered office is in Mumbai, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.00.
The company currently has active open charges totaling ₹6.06 Cr.
Company Details
- Location Mumbai, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH1979PTC021240
- Company No.
021240
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Apr 1979
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Iv-Kon Pharmaceuticals?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Iv-Kon Pharmaceuticals.
Enhance accessibility to Iv-Kon Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Iv-Kon Pharmaceuticals?
Unlock access to Iv-Kon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹60.63 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Bank Of Maharashtra : 5.81 Cr
- Bank Od Maharashtra : 0.13 Cr
- General Manager : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jan 1988 | Bank Of Maharashtra | ₹5.81 Cr | Open |
| 05 Dec 1987 | Bank Od Maharashtra | ₹1.29 M | Open |
| 20 Aug 1986 | General Manager | ₹1.20 M | Open |
How Many Employees Work at Iv-Kon Pharmaceuticals?
Unlock and access historical data on people associated with Iv-Kon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Iv-Kon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iv-Kon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.